Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 7/20 | 0.37 |
| ▸ | DGKA | P23743 | 1/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1835849 | 0.84 | MGLL (0.36) | PRKCADGKAADRA2AADRA1AMGLL | |
| SCHEMBL17565749 | 0.77 | PRKCA (0.36) | PRKCADGKA | |
| SCHEMBL4570257 | 0.76 | CTDSP1 (0.36) | PRKCA | |
| SCHEMBL135497 | 0.74 | LMNA (0.44) | — | |
| SCHEMBL14848489 | 0.73 | PRKCA (0.36) | PRKCA | |
| SCHEMBL712220 | 0.70 | MAPK1 (0.32) | — | |
| SCHEMBL1816515 | 0.70 | ADRA2A (0.48) | DGKAADRA2AADRA1AMGLL | |
| SCHEMBL4570255 | 0.70 | PRKCA (0.38) | PRKCA | |
| SCHEMBL7847493 | 0.70 | TSHR (0.46) | — | |
| SCHEMBL4570258 | 0.70 | CTDSP1 (0.38) | PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9187598-B2 | Polyhydroxy ketal ester adducts, methods of manufacture and uses thereof | SEGETIS, INC. (US) | 2015-11-17 | — | — | US | disclosed |
| US-9187598-B2 | Polyhydroxy ketal ester adducts, methods of manufacture and uses thereof | SEGETIS, INC. (US) | 2015-11-17 | — | — | US | disclosed |
| US-20120121911-A1 | POLYHYDROXY KETAL ESTER ADDUCTS, METHODS OF MANUFACTURE AND USES THEREOF | SEGETIS, INC. (US) | 2012-05-17 | — | — | US | disclosed |
| US-20120121911-A1 | POLYHYDROXY KETAL ESTER ADDUCTS, METHODS OF MANUFACTURE AND USES THEREOF | SEGETIS, INC. (US) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120121911-A1 | POLYHYDROXY KETAL ESTER ADDUCTS, METHODS OF MANUFACTURE AND USES THEREOF | ALKBH3, PHYKPL, KYAT1 | PRKCA 680/4885DGKA 443/4885ADRA2A 3820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.